Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lloyd Sems currently holds 18,196 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lloyd Sems has been a net buyer of CYCC stock. They have purchased $100.0K and sold $0 worth of shares.
Lloyd Sems's most recent insider trade was on Jun 14, 2022, when they sold 15,822 shares at $0.00 per share.
Lloyd Sems serves as Executive at Cyclacel Pharmaceuticals, Inc. (CYCC). They have executed 22 insider transactions totaling $100.0K over their tenure at the company.
Lloyd Sems holds the position of Executive at Cyclacel Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Lloyd Sems has shown a buying trading pattern, with $100.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Lloyd Sems was on Sep 12, 2013, when they purchased $210.0K worth of SLTC shares. This transaction involved 30,000 shares at $7.00 per share.
Lloyd Sems currently owns 18,196 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lloyd Sems's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lloyd Sems has 22 Form 4 filings on record as an insider at Cyclacel Pharmaceuticals, Inc..
Set alerts for Lloyd Sems and 40,000+ other insiders.